Global transcriptional profiles of Trichophyton rubrum in response to Flucytosine

Science in China, Series C: Life Sciences

Volumn 52, Issue 12, 2009, Pages 1173-1185

  Zhao, Rong ^a   Bin, Wen ^a   Diao, YouJiang ^b   Yang, Jian ^b   Liu, Tao ^b   Peng, JunPing ^b   Jin, Qi ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

5 Flucytosine; cDNA microarray; Gene expression; Trichophyton rubrum

Indexed keywords

ANTIFUNGAL AGENT; FLUCYTOSINE; FUNGAL PROTEIN;

ARTICLE; CLASSIFICATION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRICHOPHYTON;

ANTIFUNGAL AGENTS; FLUCYTOSINE; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRICHOPHYTON;

TRICHOPHYTON RUBRUM;

EID: 75649111237     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0153-x     Document Type: Article

References (58)

1. Kemna M E, Elewski B E. AUS epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol, 1996, 35: 539-542.
2. Elewsk E B. Onychomycosis: Pathogenesis, diagnosis and management. Clin Microbiol Rev, 1998, 11: 415-429.
3. Cordeiro R A, Brilhante R S, Rocha M F, et al. Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient with chronic dermatophytosis. Cli Exp Dermatol, 2006, 31: 122-124.
4. Wang L, Ma L, Leng W, et al. Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags. BMC Genomics, 2006, 7: 255-268.
5. Yang J, Chen L H, Wang L L, et al. TrED: The Trichophyton rubrum expression database. BMC Genomics, 2007, 8: 250-256.
6. Liu T, Zhang Q, Wang L, et al. The use of global transcriptional analysis to reveal the biological and cellular events involved in distinct development phases of Trichophyton rubrum conidial germination. BMC Genomics, 2007, 8: 100-114.
7. Agarwal A K, Rogers P D, Baerson S R, et al. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem, 2003, 278: 34998-35015.
8. Yu L, Zhang W, Wang L, et al. Transcriptional profiles of the response to ketocanazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Ch, 2007, 51: 144-153.
9. Diao Y J, Zhao R, Deng X M, et al. Transcriptional profiles of Trichophyton rubrum in response to itraconazole. Med Mycol, 2008, 47: 237-247.
10. Zhang W, Yu L, Leng W, et al. cDNA microarray analysis of the expression profiles of Trichophyton rubrum in response to novel synthetic fatty acid synthase inhibitor PHS11A. Fungal Genet Biol, 2007, 44: 1252-1261.
11. Polark A, Wain W H. The influence of 5-fluorocytosine on nucleic acid synthesis in C. albicans, Cr, neoformans and A. fumiguatus. Chemotherapy, 1977, 23: 243-259.
12. Wain W H, Polak A. The effect of 5-fluorocytosine on the synthesis of 80S ribosomes by pathogenic fungi. Sabouraudia, 1981, 19: 187-197.
13. Whelan W L. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit Rev Microbiol, 1987, 15: 45-56.
14. De Hoog G S, Guarro J, Gene J, et al. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures. Utrecht: The Netherlands, and University Rovirai Virgili, Reus, Spain. 2000.
15. Jackson C J, Barton R C, Evans E G. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol, 1999, 37: 931-936.
16. Peng J, Zhang X, Yang J, et al. The use of comparative genomics hybridization to characterize genome dynamics and diversity among the serotypes of Shigella. BMC Genomics, 2006, 7: 218-229.
17. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. In: National Committee for Clinical Laboratory Standards, Wayne, PA. 2002.
18. Fernandez-Torres B, Cabanes F J, Carrillo-Munoz A J, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol, 2002, 40: 3999-4003.
19. Barry A L, Pfaller M A, Brown S D, et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol, 2000, 38: 3457-3459.
20. Cleveland W S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc, 1979, 74: 829-836.
21. Saeed A I, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Bio Techniques, 2003, 34: 374-378.
22. Polak A, Scholer H J. Mode of action of 5-fluorocytosine In: E. Drouhet ed, Antifungal agents. New York: Marcel Dekker Inc., 1980.
23. Liu T T, Lee R E, Barker K S, et al. Genome-wide expression profiling of the response to Azole, Polyene, Echinocandin, and Pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Ch, 2005, 49: 2226-2236.
24. Diasio R B, Bennett J E, Myers C E. Mode of action of 5-fluorocytosine. Biochem Pharmacol, 1978, 27: 703-707.
25. Navalgund L G, Rossana C, Muench A J, et al. Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem, 1980, 255: 7386-7390.
26. Drgonová J, Drgon T, Tanaka K, et al. Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science, 1996, 272: 277-279.
27. Levin D E. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol R, 2005, 69: 262-291.
28. Santos B, Gutiérrez J, Calonge T M, et al. Novel Rho GTPase involved in cytokinesis and cell wall integrity in the fission yeast Schizosaccharomyces pombe. Eukaryot Cell, 2003, 2: 521-533.
29. Fillinger S, Chaveroche M K, Shimizu K, et al. cAMP and ras signalling independently control spore germination in the filamentous fungus Aspergillus nidulans. Mol Microbiol, 2002, 44: 1001-1016.
30. Mosch H U, Kubler E, Krappmann S, et al. Crosstalk between the Ras2p-controlled mitogen-activated protein kinase and cAMP pathways during invasive growth of Saccharomyces cerevisiae. Mol Biol Cell, 1999, 10: 1325-1335.
31. Aguiar P H, Santos D N, Lobo F P, et al. Functional complementation of a yeast knockout strain by Schistosoma mansoni Rho1 GTPase in the presence of caffeine, an agent that affects mutants defective in the protein kinase C signal transduction pathway. Mem I Oswaldo Cruz, 2006, 101(Suppl1): 323-326.
32. Felipe M S, Andrade R V, Arraes F B, et al. Transcriptional profiles of the human pathogenic fungus Paracoccidioides brasiliensis in mycelium and yeast cells. J Biol Chem, 2005, 280: 24706-24714.
33. Tutar Y. Heat shock proteins, substrate specificity and modulation of function. Protein Peptide Lett, 2006, 13: 699-705.
34. Kummasook A, Pongpom P, Vanittanakom N. Cloning, characterization and differential expression of an hsp70 gene from the pathogenic dimorphic fungus, Penicillium marneffei. DNA Sequence, 2007, 18: 385-394.
35. Wright C M, Fewell S W, Sullivan M L, et al. The Hsp40 molecular chaperone Ydj1p, along with the protein kinase C pathway, affects cell-wall integrity in the yeast Saccharomyces cerevisiae. Genetics, 2007, 175: 1649-1664.
36. Kakiuchi K, Yamauchi Y, Taoka M, et al. Proteomic analysis of in vivo 14-3-3 interactions in the yeast Saccharomyces cerevisiae. Biochem J, 2007, 46: 7781-7792.
37. Lottersberger F, Panza A, Lucchini G, et al. The Saccharomyces cerevisiae 14-3-3 proteins are required for the G1/S transition, actin cytoskeleton organization and cell wall integrity. Genetics, 2006, 173: 661-675.
38. DeGregori J, Kowalik T, Nevins J R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S-regulatory genes. Mol Cell Biol, 1995, 158: 4215-4224.
39. Wu C L, Classon M, Dyson N, et al. Expression of dominantnegative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol, 1996, 16: 3698-3706.
40. Banerjee D, Schnieders B, Fu J Z, et al. Role of E2F-1 in chemosensitivity. Cancer Res, 1998, 58: 4292-4296.
41. Giege R, Weil J H. tRNA's from yeast having incorporated 5-fluorouracil arising from in vivo deamination of 5-fluorocytosine. Bull Soc Chim Biol, 1970, 52: 135-144.
42. Polak A. Effects of 5-fluorocytosine on protein synthesis and amino acid pool in candida albicans. Sabouraudia, 1974, 12: 309-319.
43. Polak A, Scholer H J. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy, 1975, 21: 113-130.
44. Lee F J, Moss J. An RNA-binding protein gene (RBP1) of Saccharomyces cerevisiae encodes a putative glucose-repressible protein containing two RNA recognition motifs. J Biol Chem, 1993, 268: 15080-15087.
45. Winstall E, Sadowski M, Kuhn U, et al. The Saccharomyces cerevisiae RNA-binding protein Rbp29 functions in cytoplasmic mRNA metabolism. J Biol Chem, 2000, 275: 21817-21826.
46. Deng C, Saunders W S. RIM4 encodes a meiotic activator required for early events of meiosis in Saccharomyces cerevisiae. Mol Genet Genomics, 2001, 266: 497-504.
47. Dandekar T, Tollervey D. Identification and functional analysis of a novel yeast small nucleolar RNA. Nucleic Acids Res, 1993, 21: 5386-5390.
48. Papamichael D. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. Stem Cells, 2000, 18: 166-175.
49. Beggs W H, Andrews F A, Sarosi G A. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone. Chemotherapy, 1981, 27: 247-251.
50. Ghannoum, MA, Rice LB. Antifungal agents: mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev, 1999, 12: 501-517.
51. Rogers B, Decottignies A, Kolaczkowski M, et al. The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J Mol Microb Biotech, 2001, 3: 207-214.
52. Prévéral S, Ansoborlo E, Mari S, et al. Metal(loid)s and radionuclides cytotoxicity in Saccharomyces cerevisiae. Role of YCF1, glutathione and effect of buthionine sulfoximine. Biochimie, 2006, 88: 1651-1663.
53. Li Z S, Szczypka M, Lu Y P, et al. The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump. J Biol Chem, 1996, 271: 6509-6517.
54. Adamis P D, Panek A D, Eleutherio E C. Vacuolar compartmentation of the cadmium-glutathione complex protects Saccharomyces cerevisiae from mutagenesis. Toxicol Lett, 2007, 173: 1-7.
55. Tommasini R, Evers R, Vogt E, et al. The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1. Proc Natl Acad Sci USA, 1996, 93: 6743-6748.
56. Servos J, Haase E, Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Genet Genomics, 1993, 236: 214-218.
57. Akache B, Turcotte B. New regulators of drug sensitivity in the family of yeast zinc cluster proteins. J Biol Chem, 2002, 277: 21254-21260.
58. Menant A, Baudouin-Cornu P, Peyraud C, et al. Determinants of the ubiquitin-mediated degradation of the Met4 transcription factor. J Biol Chem, 2006, 281: 11744-11754.